| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed phase LC POSITIVE ION MODE | 1A_91_1_326 | Treatment:Control | AU |
| Reversed phase LC POSITIVE ION MODE | 1A_91_1_329 | Treatment:Control | AU |
| Reversed phase LC POSITIVE ION MODE | 1A_92_1_327 | Treatment:Control | AU |
| Reversed phase LC POSITIVE ION MODE | 1A_92_1_330 | Treatment:Control | AU |
| Reversed phase LC POSITIVE ION MODE | 1A_93_1_328 | Treatment:Control | AU |
| Reversed phase LC POSITIVE ION MODE | 1A_93_1_331 | Treatment:Control | AU |
| Reversed phase LC POSITIVE ION MODE | 2a-1_57_1_436 | Treatment:TAMOXIFEN | AU |
| Reversed phase LC POSITIVE ION MODE | 2a_-1_58_1_438 | Treatment:TAMOXIFEN | AU |
| Reversed phase LC POSITIVE ION MODE | 2a_-1_59_1_440 | Treatment:TAMOXIFEN | AU |
| Reversed phase LC POSITIVE ION MODE | 2a-2_57_1_437 | Treatment:TAMOXIFEN | AU |
| Reversed phase LC POSITIVE ION MODE | 2a_-2_58_1_439 | Treatment:TAMOXIFEN | AU |
| Reversed phase LC POSITIVE ION MODE | 2a_-2_59_1_441 | Treatment:TAMOXIFEN | AU |
Return to study ST002317 main page
Download data matrix(Mass spectroscopy‑based proteomics and metabolomics analysis of triple‑positive breast cancer cells treated with tamoxifen Reversed phase LC POSITIVE ION MODE)
- Metabolomics Workbench
|